Healthcare antitrust, settlements, and the Federal Trade Commission:
This volume of Research in Law and Economics contains articles that address important legal and economic developments in the areas of healthcare, intellectual property and labor settlements, competitive effects, cartel overcharges, and the U.S. Federal Trade Commission ("FTC"). Four of the...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Bingley, U.K.
Emerald Publishing Limited
2018
|
| Schriftenreihe: | Research in law and economics
volume 28 |
| Schlagworte: | |
| Online-Zugang: | DE-634 DE-1043 DE-M347 DE-523 DE-91 DE-473 DE-19 DE-355 DE-703 DE-20 DE-706 DE-824 DE-29 DE-739 Volltext |
| Zusammenfassung: | This volume of Research in Law and Economics contains articles that address important legal and economic developments in the areas of healthcare, intellectual property and labor settlements, competitive effects, cartel overcharges, and the U.S. Federal Trade Commission ("FTC"). Four of the articles were initially presented at a conference on healthcare competition in Washington, D.C., which was sponsored by the American Antitrust Institute, this journal, and Navigant Economics. These articles explore practices that are under challenge in pharmaceuticals, where the Federal Trade Commission has been extremely active, as well as issues involving hospital and health insurance mergers. They are followed by a long and detailed discussion of the current and historic role of economists and economic analysis at the Federal Trade Commission. The next two articles analyze different aspects of the French economy, pre-trial labor settlements and the impact of e-commerce on franchisees. The volume ends with three technical economics articles one on "upward pricing pressure", one on estimating price increases in cartel cases, and one critiquing a "meta-analysis" of research on the effectiveness of U.S. merger regulation. Taken together, these articles raise questions about appropriate competition policy, how to evaluate settlements and other firm behavior, and where economics and competition policy are headed |
| Beschreibung: | Includes index |
| Beschreibung: | 1 Online-Ressource (xvii, 464 Seiten) cm |
| ISBN: | 9781787565999 |
Internformat
MARC
| LEADER | 00000nmm a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV048846643 | ||
| 003 | DE-604 | ||
| 005 | 20240103 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 230306s2018 |||| o||u| ||||||eng d | ||
| 020 | |a 9781787565999 |q ebook |9 978-1-78756-599-9 | ||
| 024 | 7 | |a 10.1108/S0193-5895201828 |2 doi | |
| 035 | |a (ZDB-1-EPB)9781787565999 | ||
| 035 | |a (DE-599)BVBBV048846643 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-634 |a DE-1043 |a DE-M347 |a DE-523 |a DE-91 |a DE-473 |a DE-19 |a DE-355 |a DE-703 |a DE-20 |a DE-706 |a DE-824 |a DE-29 |a DE-739 | ||
| 084 | |a PA 1000 |0 (DE-625)134985: |2 rvk | ||
| 084 | |a QX 780 |0 (DE-625)142198: |2 rvk | ||
| 245 | 1 | 0 | |a Healthcare antitrust, settlements, and the Federal Trade Commission |c edited by James Langenfeld and Edwin Galeano |
| 264 | 1 | |a Bingley, U.K. |b Emerald Publishing Limited |c 2018 | |
| 264 | 4 | |c ©2018 | |
| 300 | |a 1 Online-Ressource (xvii, 464 Seiten) |c cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Research in law and economics |v volume 28 | |
| 500 | |a Includes index | ||
| 505 | 8 | |a Prelims -- "To know where youre going, look at where youve been" -- Actavis, authorized generics, and the future of antitrust law -- Solving the product-hopping conundrum through safe harbors and a no-economic-sense test -- A market all its own: medicare advantage as a separate product market in the DOJs case against the Aetna-Humana Merger -- A history of the FTCs Bureau of Economics -- Labor disputes and pretrial settlements: the French case -- Franchisees facing online sales in a European legal context -- Mandatory upstream inputs and upward pricing pressure: implications for competition policy -- When is the "Kennedy Correction" appropriate in estimating overcharges? -- Kwokas mergers, merger control, and remedies: rejoinder to Kwoka -- Index | |
| 520 | 3 | |a This volume of Research in Law and Economics contains articles that address important legal and economic developments in the areas of healthcare, intellectual property and labor settlements, competitive effects, cartel overcharges, and the U.S. Federal Trade Commission ("FTC"). Four of the articles were initially presented at a conference on healthcare competition in Washington, D.C., which was sponsored by the American Antitrust Institute, this journal, and Navigant Economics. These articles explore practices that are under challenge in pharmaceuticals, where the Federal Trade Commission has been extremely active, as well as issues involving hospital and health insurance mergers. They are followed by a long and detailed discussion of the current and historic role of economists and economic analysis at the Federal Trade Commission. The next two articles analyze different aspects of the French economy, pre-trial labor settlements and the impact of e-commerce on franchisees. The volume ends with three technical economics articles one on "upward pricing pressure", one on estimating price increases in cartel cases, and one critiquing a "meta-analysis" of research on the effectiveness of U.S. merger regulation. Taken together, these articles raise questions about appropriate competition policy, how to evaluate settlements and other firm behavior, and where economics and competition policy are headed | |
| 610 | 2 | 7 | |a USA |b Federal Trade Commission |0 (DE-588)43213-1 |2 gnd |9 rswk-swf |
| 650 | 7 | |a Business & Economics |2 Economics | |
| 650 | 4 | |a Economics | |
| 650 | 4 | |a Antitrust law |z United States | |
| 650 | 4 | |a Medical care |x Law and legislation |z United States | |
| 650 | 0 | 7 | |a Medizinische Versorgung |0 (DE-588)4038270-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Wettbewerbsregeln |0 (DE-588)4189757-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a USA |b Federal Trade Commission |0 (DE-588)43213-1 |D b |
| 689 | 0 | 1 | |a Medizinische Versorgung |0 (DE-588)4038270-9 |D s |
| 689 | 0 | 2 | |a Wettbewerbsregeln |0 (DE-588)4189757-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Galeano, Edwin |4 edt | |
| 700 | 1 | |a Langenfeld, James |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 9781787566002 |
| 856 | 4 | 0 | |u https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-1-EPB | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-034111984 | |
| 966 | e | |u https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828 |l DE-634 |p ZDB-1-EPB |x Verlag |3 Volltext | |
| 966 | e | |u https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828 |l DE-1043 |p ZDB-1-EPB |x Verlag |3 Volltext | |
| 966 | e | |u https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828 |l DE-M347 |p ZDB-1-EPB |x Verlag |3 Volltext | |
| 966 | e | |u https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828 |l DE-523 |p ZDB-1-EPB |x Verlag |3 Volltext | |
| 966 | e | |u https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828 |l DE-91 |p ZDB-1-EPB |x Verlag |3 Volltext | |
| 966 | e | |u https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828 |l DE-473 |p ZDB-1-EPB |x Verlag |3 Volltext | |
| 966 | e | |u https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828 |l DE-19 |p ZDB-1-EPB |x Verlag |3 Volltext | |
| 966 | e | |u https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828 |l DE-355 |p ZDB-1-EPB |x Verlag |3 Volltext | |
| 966 | e | |u https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828 |l DE-703 |p ZDB-1-EPB |x Verlag |3 Volltext | |
| 966 | e | |u https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828 |l DE-20 |p ZDB-1-EPB |x Verlag |3 Volltext | |
| 966 | e | |u https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828 |l DE-706 |p ZDB-1-EPB |x Verlag |3 Volltext | |
| 966 | e | |u https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828 |l DE-824 |p ZDB-1-EPB |x Verlag |3 Volltext | |
| 966 | e | |u https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828 |l DE-29 |p ZDB-1-EPB |x Verlag |3 Volltext | |
| 966 | e | |u https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828 |l DE-739 |p ZDB-1-EPB |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1806233010514690048 |
|---|---|
| adam_text | |
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author2 | Galeano, Edwin Langenfeld, James |
| author2_role | edt edt |
| author2_variant | e g eg j l jl |
| author_facet | Galeano, Edwin Langenfeld, James |
| building | Verbundindex |
| bvnumber | BV048846643 |
| classification_rvk | PA 1000 QX 780 |
| collection | ZDB-1-EPB |
| contents | Prelims -- "To know where youre going, look at where youve been" -- Actavis, authorized generics, and the future of antitrust law -- Solving the product-hopping conundrum through safe harbors and a no-economic-sense test -- A market all its own: medicare advantage as a separate product market in the DOJs case against the Aetna-Humana Merger -- A history of the FTCs Bureau of Economics -- Labor disputes and pretrial settlements: the French case -- Franchisees facing online sales in a European legal context -- Mandatory upstream inputs and upward pricing pressure: implications for competition policy -- When is the "Kennedy Correction" appropriate in estimating overcharges? -- Kwokas mergers, merger control, and remedies: rejoinder to Kwoka -- Index |
| ctrlnum | (ZDB-1-EPB)9781787565999 (DE-599)BVBBV048846643 |
| discipline | Rechtswissenschaft Wirtschaftswissenschaften |
| discipline_str_mv | Rechtswissenschaft Wirtschaftswissenschaften |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nmm a2200000 cb4500</leader><controlfield tag="001">BV048846643</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240103</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">230306s2018 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781787565999</subfield><subfield code="q">ebook</subfield><subfield code="9">978-1-78756-599-9</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1108/S0193-5895201828</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-1-EPB)9781787565999</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048846643</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-634</subfield><subfield code="a">DE-1043</subfield><subfield code="a">DE-M347</subfield><subfield code="a">DE-523</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-706</subfield><subfield code="a">DE-824</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-739</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PA 1000</subfield><subfield code="0">(DE-625)134985:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QX 780</subfield><subfield code="0">(DE-625)142198:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Healthcare antitrust, settlements, and the Federal Trade Commission</subfield><subfield code="c">edited by James Langenfeld and Edwin Galeano</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Bingley, U.K.</subfield><subfield code="b">Emerald Publishing Limited</subfield><subfield code="c">2018</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xvii, 464 Seiten)</subfield><subfield code="c">cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Research in law and economics</subfield><subfield code="v">volume 28</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes index</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Prelims -- "To know where youre going, look at where youve been" -- Actavis, authorized generics, and the future of antitrust law -- Solving the product-hopping conundrum through safe harbors and a no-economic-sense test -- A market all its own: medicare advantage as a separate product market in the DOJs case against the Aetna-Humana Merger -- A history of the FTCs Bureau of Economics -- Labor disputes and pretrial settlements: the French case -- Franchisees facing online sales in a European legal context -- Mandatory upstream inputs and upward pricing pressure: implications for competition policy -- When is the "Kennedy Correction" appropriate in estimating overcharges? -- Kwokas mergers, merger control, and remedies: rejoinder to Kwoka -- Index</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">This volume of Research in Law and Economics contains articles that address important legal and economic developments in the areas of healthcare, intellectual property and labor settlements, competitive effects, cartel overcharges, and the U.S. Federal Trade Commission ("FTC"). Four of the articles were initially presented at a conference on healthcare competition in Washington, D.C., which was sponsored by the American Antitrust Institute, this journal, and Navigant Economics. These articles explore practices that are under challenge in pharmaceuticals, where the Federal Trade Commission has been extremely active, as well as issues involving hospital and health insurance mergers. They are followed by a long and detailed discussion of the current and historic role of economists and economic analysis at the Federal Trade Commission. The next two articles analyze different aspects of the French economy, pre-trial labor settlements and the impact of e-commerce on franchisees. The volume ends with three technical economics articles one on "upward pricing pressure", one on estimating price increases in cartel cases, and one critiquing a "meta-analysis" of research on the effectiveness of U.S. merger regulation. Taken together, these articles raise questions about appropriate competition policy, how to evaluate settlements and other firm behavior, and where economics and competition policy are headed</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">USA</subfield><subfield code="b">Federal Trade Commission</subfield><subfield code="0">(DE-588)43213-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Business & Economics</subfield><subfield code="2">Economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antitrust law</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical care</subfield><subfield code="x">Law and legislation</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Medizinische Versorgung</subfield><subfield code="0">(DE-588)4038270-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wettbewerbsregeln</subfield><subfield code="0">(DE-588)4189757-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="b">Federal Trade Commission</subfield><subfield code="0">(DE-588)43213-1</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Medizinische Versorgung</subfield><subfield code="0">(DE-588)4038270-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Wettbewerbsregeln</subfield><subfield code="0">(DE-588)4189757-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Galeano, Edwin</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Langenfeld, James</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">9781787566002</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-EPB</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034111984</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828</subfield><subfield code="l">DE-634</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828</subfield><subfield code="l">DE-1043</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828</subfield><subfield code="l">DE-M347</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828</subfield><subfield code="l">DE-523</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828</subfield><subfield code="l">DE-91</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828</subfield><subfield code="l">DE-473</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828</subfield><subfield code="l">DE-19</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828</subfield><subfield code="l">DE-355</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828</subfield><subfield code="l">DE-703</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828</subfield><subfield code="l">DE-20</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828</subfield><subfield code="l">DE-706</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828</subfield><subfield code="l">DE-824</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828</subfield><subfield code="l">DE-29</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828</subfield><subfield code="l">DE-739</subfield><subfield code="p">ZDB-1-EPB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV048846643 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T21:39:05Z |
| indexdate | 2024-08-02T00:20:31Z |
| institution | BVB |
| isbn | 9781787565999 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034111984 |
| open_access_boolean | |
| owner | DE-634 DE-1043 DE-M347 DE-523 DE-91 DE-BY-TUM DE-473 DE-BY-UBG DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-703 DE-20 DE-706 DE-824 DE-29 DE-739 |
| owner_facet | DE-634 DE-1043 DE-M347 DE-523 DE-91 DE-BY-TUM DE-473 DE-BY-UBG DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-703 DE-20 DE-706 DE-824 DE-29 DE-739 |
| physical | 1 Online-Ressource (xvii, 464 Seiten) cm |
| psigel | ZDB-1-EPB |
| publishDate | 2018 |
| publishDateSearch | 2018 |
| publishDateSort | 2018 |
| publisher | Emerald Publishing Limited |
| record_format | marc |
| series2 | Research in law and economics |
| spelling | Healthcare antitrust, settlements, and the Federal Trade Commission edited by James Langenfeld and Edwin Galeano Bingley, U.K. Emerald Publishing Limited 2018 ©2018 1 Online-Ressource (xvii, 464 Seiten) cm txt rdacontent c rdamedia cr rdacarrier Research in law and economics volume 28 Includes index Prelims -- "To know where youre going, look at where youve been" -- Actavis, authorized generics, and the future of antitrust law -- Solving the product-hopping conundrum through safe harbors and a no-economic-sense test -- A market all its own: medicare advantage as a separate product market in the DOJs case against the Aetna-Humana Merger -- A history of the FTCs Bureau of Economics -- Labor disputes and pretrial settlements: the French case -- Franchisees facing online sales in a European legal context -- Mandatory upstream inputs and upward pricing pressure: implications for competition policy -- When is the "Kennedy Correction" appropriate in estimating overcharges? -- Kwokas mergers, merger control, and remedies: rejoinder to Kwoka -- Index This volume of Research in Law and Economics contains articles that address important legal and economic developments in the areas of healthcare, intellectual property and labor settlements, competitive effects, cartel overcharges, and the U.S. Federal Trade Commission ("FTC"). Four of the articles were initially presented at a conference on healthcare competition in Washington, D.C., which was sponsored by the American Antitrust Institute, this journal, and Navigant Economics. These articles explore practices that are under challenge in pharmaceuticals, where the Federal Trade Commission has been extremely active, as well as issues involving hospital and health insurance mergers. They are followed by a long and detailed discussion of the current and historic role of economists and economic analysis at the Federal Trade Commission. The next two articles analyze different aspects of the French economy, pre-trial labor settlements and the impact of e-commerce on franchisees. The volume ends with three technical economics articles one on "upward pricing pressure", one on estimating price increases in cartel cases, and one critiquing a "meta-analysis" of research on the effectiveness of U.S. merger regulation. Taken together, these articles raise questions about appropriate competition policy, how to evaluate settlements and other firm behavior, and where economics and competition policy are headed USA Federal Trade Commission (DE-588)43213-1 gnd rswk-swf Business & Economics Economics Economics Antitrust law United States Medical care Law and legislation United States Medizinische Versorgung (DE-588)4038270-9 gnd rswk-swf Wettbewerbsregeln (DE-588)4189757-2 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content USA Federal Trade Commission (DE-588)43213-1 b Medizinische Versorgung (DE-588)4038270-9 s Wettbewerbsregeln (DE-588)4189757-2 s DE-604 Galeano, Edwin edt Langenfeld, James edt Erscheint auch als Druckausgabe 9781787566002 https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Healthcare antitrust, settlements, and the Federal Trade Commission Prelims -- "To know where youre going, look at where youve been" -- Actavis, authorized generics, and the future of antitrust law -- Solving the product-hopping conundrum through safe harbors and a no-economic-sense test -- A market all its own: medicare advantage as a separate product market in the DOJs case against the Aetna-Humana Merger -- A history of the FTCs Bureau of Economics -- Labor disputes and pretrial settlements: the French case -- Franchisees facing online sales in a European legal context -- Mandatory upstream inputs and upward pricing pressure: implications for competition policy -- When is the "Kennedy Correction" appropriate in estimating overcharges? -- Kwokas mergers, merger control, and remedies: rejoinder to Kwoka -- Index USA Federal Trade Commission (DE-588)43213-1 gnd Business & Economics Economics Economics Antitrust law United States Medical care Law and legislation United States Medizinische Versorgung (DE-588)4038270-9 gnd Wettbewerbsregeln (DE-588)4189757-2 gnd |
| subject_GND | (DE-588)43213-1 (DE-588)4038270-9 (DE-588)4189757-2 (DE-588)4143413-4 |
| title | Healthcare antitrust, settlements, and the Federal Trade Commission |
| title_auth | Healthcare antitrust, settlements, and the Federal Trade Commission |
| title_exact_search | Healthcare antitrust, settlements, and the Federal Trade Commission |
| title_exact_search_txtP | Healthcare antitrust, settlements, and the Federal Trade Commission |
| title_full | Healthcare antitrust, settlements, and the Federal Trade Commission edited by James Langenfeld and Edwin Galeano |
| title_fullStr | Healthcare antitrust, settlements, and the Federal Trade Commission edited by James Langenfeld and Edwin Galeano |
| title_full_unstemmed | Healthcare antitrust, settlements, and the Federal Trade Commission edited by James Langenfeld and Edwin Galeano |
| title_short | Healthcare antitrust, settlements, and the Federal Trade Commission |
| title_sort | healthcare antitrust settlements and the federal trade commission |
| topic | USA Federal Trade Commission (DE-588)43213-1 gnd Business & Economics Economics Economics Antitrust law United States Medical care Law and legislation United States Medizinische Versorgung (DE-588)4038270-9 gnd Wettbewerbsregeln (DE-588)4189757-2 gnd |
| topic_facet | USA Federal Trade Commission Business & Economics Economics Antitrust law United States Medical care Law and legislation United States Medizinische Versorgung Wettbewerbsregeln Aufsatzsammlung |
| url | https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828 |
| work_keys_str_mv | AT galeanoedwin healthcareantitrustsettlementsandthefederaltradecommission AT langenfeldjames healthcareantitrustsettlementsandthefederaltradecommission |